
Crestview plans to allocate additional equity to support Smyth’s organic investments and M&As.
NYC-based Crestview Partners, a leading private-equity firm, wraps its acquisition of Smyth Companies, the MN-based provider of pressure-sensitive labels, shrink sleeves, in-mold labels, glue-applied labels, and flexible packaging, from Novacap. Crestview is investing alongside members of the company’s founding family and the existing management team led by President & CEO Scott Fisher, who will continue to lead the company. Terms of the deal were not disclosed.
As part of the transaction, Crestview is allocating additional equity to support organic investments and M&A to drive enhanced capabilities, scale and diversification; and Smyth is actively pursuing both tuck-in and transformational acquisitions across the p-s labels, shrink sleeve, in-mold labels and flexible-packaging markets.
Headquartered in Eagan, Smyth is a leader in the prime-labels industry, providing customized solutions for a diverse array of high-value consumer product applications across the household, food, HBA and automotive-aftermarket segments. Smyth’s broad range of printing capabilities, highly-regarded product quality and reputation for exceptional customer service have resulted in strong, long-tenured partnerships with numerous blue-chip consumer packaged goods customers, many of which have trusted Smyth to serve their most iconic brands for decades.
Bradford Williams, partner and co-head-Industrials at Crestview, says, “We believe Smyth holds a strong position within the broader prime-labels market driven by its innovative, customer-first approach, comprehensive product portfolio, and reputation for exceptional product quality, which enable the company to flexibly serve leading CPG customers. Smyth’s strong presence in attractive end-markets has allowed it to experience a high degree of stability across economic cycles and positioned it well to capitalize on numerous tailwinds. These characteristics make our investment in Smyth highly consistent with Crestview’s strategy of investing in market-leading businesses.”